Understanding blood sugar levels and their effects during pregnancy
Glycemic Profiles and Pregnancy Outcomes Study (GLOSS)
This study is looking at how using continuous glucose monitors can help pregnant women with gestational diabetes keep track of their blood sugar levels, so they can better manage their health and improve outcomes for themselves and their babies.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10919208 on NIH RePORTER |
What this research studies
This research investigates how continuous glucose monitoring can help identify and manage gestational diabetes mellitus (GDM) by tracking blood sugar levels throughout pregnancy. By analyzing glucose profiles over time, the study aims to understand the relationship between maternal blood sugar levels and pregnancy outcomes for both mothers and their children. The goal is to improve early detection and treatment of GDM, potentially leading to better health outcomes. Participants will be monitored closely to gather data on their glucose levels and related health metrics.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant women, particularly those at risk for gestational diabetes or those in their first or third trimester.
Not a fit: Patients who are not pregnant or those who do not have any risk factors for gestational diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved management of gestational diabetes, resulting in healthier pregnancies and better long-term health for mothers and their children.
How similar studies have performed: Previous research has shown promise in using continuous glucose monitoring for managing diabetes, suggesting that this approach may be beneficial for gestational diabetes as well.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Yee, Lynn M — Northwestern University at Chicago
- Study coordinator: Yee, Lynn M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.